LMF
CORT icon

LMR Master Fund’s Corcept Therapeutics CORT Stock Holding History

LMR Master Fund’s Portfolio CORT Stock Details CORT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		$84K Buy
+25,951
New +$52.5K 0.01% 329

Other funds holding CORT

Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
ISL
Ingalls & Snyder LLC New York $2.83B AUM 21.61% 1-Year Est. Return
IA
Investor AB Stockholm, Sweden $15.1B AUM 29.02% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

LMR Master Fund's CORT Position: Q4 2013 in Review

LMR Master Fund opened a new position in Corcept Therapeutics (CORT) in Q4 2013: 25,951 shares worth $84K. The stake represents 0.01% of the portfolio and ranks #329 among its holdings.

49 funds tracked by Wall St. Rank hold CORT as of Q4 2013.

  • LMR Master Fund held 25,951 shares of Corcept Therapeutics worth $84K as of Q4 2013.
  • Corcept Therapeutics was a new LMR Master Fund position in Q4 2013.
  • Corcept Therapeutics made up 0.01% of LMR Master Fund's portfolio in Q4 2013, its #329 holding.
  • 49 funds tracked by Wall St. Rank held Corcept Therapeutics as of Q4 2013.

Based on LMR Master Fund's 13F filing for Q4 2013, filed 14 Feb 2014.